Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...

Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...